Success Metrics

Clinical Success Rate

33.3%

Based on 1 completed trials

Completion Rate

33%(1/3)

Active Trials

1(25%)

Results Posted

300%(3 trials)

Terminated

2(50%)

Phase Distribution

Ph phase_2

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(2)

Detailed Status

Terminated2

Recruiting1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

33.3%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (75.0%)

Phase 31 (25.0%)

Trials by Status

recruiting125%

terminated250%

completed125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingphase_3

Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy

NCT05169112

terminatedphase_2

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

NCT01326312

completedphase_2

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

NCT02059213

terminatedphase_2

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

NCT00683917

Clinical Trials (4)

Showing 4 of 4 trials

NCT05169112Phase 3

Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy

Recruiting

NCT01326312Phase 2

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Terminated

NCT02059213Phase 2

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Completed

NCT00683917Phase 2

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4